Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma. [electronic resource]
Producer: 19971125Description: 898-906; discussion 906-7 p. digitalISSN:- 0148-396X
- Animals
- Antigens, Neoplasm
- Brain
- Brain Neoplasms -- immunology
- Female
- Fibroblasts
- Genetic Engineering
- Genetic Therapy
- Glioma -- immunology
- Humans
- Immunotherapy, Adoptive
- Injections
- Injections, Subcutaneous
- Interleukin-2 -- administration & dosage
- Melanoma, Experimental -- immunology
- Melanoma-Specific Antigens
- Mice
- Mice, Inbred C57BL
- Neoplasm Proteins -- genetics
- Neoplasm Transplantation
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.